Klockner Pentaplast Expands in North America to Support the Pharmaceutical Market

Klöckner Pentaplast, a manufacturer of pharmaceutical barrier packaging films, broke ground on a large expansion at its Klöckner Barrier Film (KBF) facility in central Virginia in the United States.

The multi-million dollar investment will increase the facility’s capacity by 6,000 sq ft and will add innovative coating capabilities, enhancing Klöckner’s ability to serve the growing North American market with high-quality pharmaceutical films.

The increased coating capabilities will uniquely position Klöckner to support the packaging needs of pharmaceutical manufacturers. “We are committed to supporting our customers as they grow and innovate,” said Tracey Peacock, President of the Pharmaceutical, Health & Specialties division. “As the market expands, the need for high-barrier solutions will grow with it. Sensitive pharmaceuticals must be protected from moisture and oxygen, which is the hallmark of our coating technology. Combined with the collaborative package design and testing capabilities of our nearby leading innovation hub – the ‘kp i.center’ in Charlottesville, we can help customers achieve new performance levels in barrier protection, and accelerate their time to market.”

About Klöckner Pentaplast
Focused on delivering its vision: The Sustainable Protection of Everyday Needs, kp is a global leader in rigid and flexible packaging, specialty film solutions, serving the pharmaceutical, medical device, food, beverage and card markets, amongst others. With a broad and innovative portfolio of packaging and product films and services, kp plays an integral role in the customer value chain by safeguarding product integrity, assuring safety and consumer health, improving sustainability and protecting brand reputation. Founded in 1965 kp has 32 plants in 18 countries and employs over 6,200 people committed to serving customers worldwide in over 60 locations.